BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30098297)

  • 1. Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.
    Gombodorj N; Yokobori T; Tanaka N; Suzuki S; Kuriyama K; Kumakura Y; Yoshida T; Sakai M; Sohda M; Baatar S; Miyazaki T; Nishiyama M; Shirabe K; Kuwano H
    J Surg Oncol; 2018 Jul; 118(1):101-108. PubMed ID: 30098297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
    Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
    Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNF750 Expression as a Novel Candidate Biomarker of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma.
    Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Iida K; Matsubara H
    Oncology; 2017; 93(3):197-203. PubMed ID: 28558382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Tamotsu K; Okumura H; Uchikado Y; Kita Y; Sasaki K; Omoto I; Owaki T; Arigami T; Uenosono Y; Nakajo A; Kijima Y; Ishigami S; Natsugoe S
    BMC Cancer; 2015 Apr; 15():323. PubMed ID: 25924824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of 18f-Fluorodeoxyglucose Positron Emission Tomography for Predicting the Pathological Response of Neoadjuvant Chemoradiotherapy for T4 Esophageal Squamous Cell Carcinoma.
    Sakai M; Sohda M; Miyazaki T; Honjo H; Hara K; Ozawa D; Suzuki S; Tanaka N; Yokobori T; Kuwano H
    Hepatogastroenterology; 2015 Jun; 62(140):898-901. PubMed ID: 26902024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of initial induction chemotherapy with 5-fluorouracil, cisplatin, and docetaxel (DCF) for T4 esophageal cancer: a propensity score-matched analysis.
    Makino T; Yamasaki M; Miyazaki Y; Wada N; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29190316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
    Satake H; Tahara M; Mochizuki S; Kato K; Hara H; Yokota T; Kiyota N; Kii T; Chin K; Zenda S; Kojima T; Bando H; Yamazaki T; Iwasa S; Honma Y; Hamauchi S; Tsushima T; Ohtsu A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):91-9. PubMed ID: 27193097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer.
    Zhang JL; Wang HY; Yang Q; Lin SY; Luo GY; Zhang R; Xu GL
    World J Gastroenterol; 2015 Apr; 21(14):4240-7. PubMed ID: 25892874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study.
    Hihara J; Hamai Y; Emi M; Murakami Y; Kenjo M; Nagata Y; Okada M
    Dis Esophagus; 2016 Nov; 29(8):1115-1120. PubMed ID: 26471962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
    Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Kawasaki Y; Okumura H; Uchikado Y; Kita Y; Sasaki K; Owaki T; Ishigami S; Natsugoe S
    Ann Surg Oncol; 2014 Jul; 21(7):2347-52. PubMed ID: 24599410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
    Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
    J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podoplanin and SOX2 expression in esophageal squamous cell carcinoma after neoadjuvant chemo-radiotherapy.
    Saigusa S; Mohri Y; Ohi M; Toiyama Y; Ishino Y; Okugawa Y; Tanaka K; Inoue Y; Kusunoki M
    Oncol Rep; 2011 Nov; 26(5):1069-74. PubMed ID: 21811761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.
    He LR; Liu MZ; Li BK; Rao HL; Deng HX; Guan XY; Zeng YX; Xie D
    Cancer Sci; 2009 Sep; 100(9):1591-6. PubMed ID: 19552757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
    Hatogai K; Fujii S; Kojima T; Daiko H; Kadota T; Fujita T; Yoshino T; Doi T; Takiguchi Y; Ohtsu A
    J Surg Oncol; 2016 Mar; 113(4):390-6. PubMed ID: 27100024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of the oldest old patient with advanced esophageal cancer responding completely to the combination chemotherapy of docetaxel/5-fluorouracil/nedaplatin with radiation].
    Matsutani T; Sasajima K; Maruyama H; Suzuki S; Miyamoto M; Yokoyama T; Yanagi K; Matsushita A; Matsuda A; Tajiri T
    Nihon Shokakibyo Gakkai Zasshi; 2009 Jul; 106(7):1026-30. PubMed ID: 19578310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.